Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

J Infect Public Health. 2020 Oct;13(10):1544-1550. doi: 10.1016/j.jiph.2020.06.030. Epub 2020 Jul 1.

Abstract

Background: Middle East respiratory syndrome coronavirus (MERS-CoV) has continued to cause sporadic outbreaks of severe respiratory tract infection over the last 8 years.

Methods: Complete genome sequencing using next-generation sequencing was performed for MERS-CoV isolates from cases that occurred in Riyadh between 2015 and 2019. Phylogenetic analysis and molecular mutational analysis were carried out to investigate disease severity.

Results: A total of eight MERS-CoV isolates were subjected to complete genome sequencing. Phylogenetic analysis resulted in the assembly of 7/8 sequences within lineage 3 and one sequence within lineage 4 showing complex genomic recombination. The isolates contained a variety of unique amino acid substitutions in ORF1ab (41), the N protein (10), the S protein (9) and ORF4b (5).

Conclusion: Our study shows that MERS-CoV is evolving. The emergence of new variants carries the potential for increased virulence and could impose a challenge to the global health system. We recommend the sequencing every new MERS-CoV isolate to observe the changes in the virus and relate them to clinical outcomes.

Keywords: MERS-CoV; SARS-CoV; Saudi Arabia; Substitutions; Zoonosis.

MeSH terms

  • Adult
  • Aged
  • Amino Acids / genetics
  • Coronavirus Infections / virology*
  • Coronavirus Nucleocapsid Proteins
  • Female
  • Humans
  • Male
  • Middle Aged
  • Middle East Respiratory Syndrome Coronavirus / genetics*
  • Mutation*
  • Nucleocapsid Proteins / genetics
  • Phylogeny
  • RNA, Viral / analysis*
  • Saudi Arabia
  • Virulence / genetics
  • Whole Genome Sequencing

Substances

  • Amino Acids
  • Coronavirus Nucleocapsid Proteins
  • Nucleocapsid Proteins
  • RNA, Viral